Science-Based Risk Assessment for Nontarget Effects of Transgenic Crops

Nontarget risk assessment for transgenic crops should be case-specific, depending on the plant, the transgene, and the intended release environment. […]

Beyond ‘substantial equivalence’

Showing that a genetically modified food is chemically similar to its natural counterpart is not adequate evidence that it is safe for human consumption. […]

Uso y abuso del principio Precautorio

Dr Peter Saunders, Prof of Mathematics at King’s College, London provides a clear and common sense approach to understanding the precautionary principle. This understanding is crucial in the light of the Biosafety Protocol. […]

Public Participation and the Cartagena Protocol on Biosafety

This study looks at public participation in the development of National Biosafety Frameworks. […]

Argentina’s Bitter Harvest

When genetically modified soya came on the scene it seemed like a heaven-sent solution to Argentina’s agricultural problems. Now soya is being blamed for an environmental crisis that is threatening the country’s fragile economic recovery. Sue Branford d […]

Submission of Third World Network relating to the development of a liability and redress regime under the Cartagena Protocol on Biosafety

Submission from Third World Network to the Open-Ended Working Group of Legal and Technical Experts on Liability and Redress in the context of the Cartagena Protocol on Biosafety. […]

Submission on Application A549 Food Derived from High Lysine Corn LY038: to permit the use in food of high lysine corn

This submission from the New Zealand Institute of Gene Ecology is to support Food Standards Australia/New Zealand’s preparation of an application to amend the Australia New Zealand Food Standards Code to allow foods derived from corn line LY038. […]

The Biosafety Clearing House: Considerations and Caveats

What has been achieved with the BCH is remarkable but the BCH is NOT sufficient to all the tasks required under the Cartegena Biosafety Protocol, nor does it contain the reliable and comprehensive information necessary for biosafety decision-making. […]

Plant-made Pharmaceuticals: Financial Risk Profile

While the biopharmaceutical industry as a whole has had some limited success, attempts to employ GE plants as a production platform for “plant-made pharmaceuticals” have foundered despite 15 years’ of field trials and huge infusions of capital. […]

Bt Cotton in Andhra Pradesh: A three-year assessment

This study announces the results of a three-year study (2002-2005) of the impact of bollworm resistant Bt cotton in Andhra Pradesh in India. The results of the survey revealed that Monsanto hybrids were utter failure compared to the Non-Bt hybrids. […]